The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
JSKN016, a first-in-class anti-TROP2/HER3 bispecific antibody-drug conjugate (ADC), in patients (pts) with HER2-negative locally advanced or metastatic breast cancer: Results from a phase I study.
 
Herui Yao
No Relationships to Disclose
 
Zhangzhou Huang
No Relationships to Disclose
 
Hong Zong
No Relationships to Disclose
 
Min Yan
No Relationships to Disclose
 
Yanxia Zhao
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Jieqiong Liu
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Yu Cao
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Xinghua Han
No Relationships to Disclose
 
Li Sun
No Relationships to Disclose
 
Xinhong Wu
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Jianjun Tang
No Relationships to Disclose
 
Jinhua Wen
No Relationships to Disclose
 
Haijun Yu
No Relationships to Disclose
 
Fang Su
No Relationships to Disclose
 
Huan Zhou
No Relationships to Disclose
 
Qi Dang
No Relationships to Disclose